Cancer and Immunity: Development of Autoantibody Biomarker Measurement Technology
La Maison Universitaire France-Japon, en collaboration avec The Japan Society for the Promotion of Science (JSPS) et l’Institut du Médicament (IMS), a le plaisir de vous convier à la conférence de:
Ass. Prof. Ai MIYAMOTO
Faculty of Interdisciplinary Science and Engineering in Health Systems, Okayama University
Sur le thème :
« Cancer and Immunity: Development of Autoantibody Biomarker Measurement Technology »
INSCRIPTION OBLIGATOIRE: mujapon@unistra.fr
Conférence tout public – en anglais
Mardi 17 Décembre 2024 à 17h30
à la Maison Universitaire France-Japon
42a, Avenue de la Forêt Noire à Strasbourg
Résumé:
Our immune system protects us by identifying and eliminating abnormal cells in the body. However, if this system stops working properly, it can lead to the development of cancer. In our research, we are focusing on autoantibodies as a way to understand how the immune system works.
These autoantibodies are indicators (biomarkers) for the level of activation of the immune system. We are developing a system (MUSCAT-assay) that can measure these autoantibodies using a small amount of blood to help diagnose cancer and predict treatment response.
